Vanda Pharmaceuticals (VNDA) Reports Q1 EPS of $0.06
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.87 -3.77%
Revenue Growth %: +17.1%
Financial Fact:
Income (loss) from operations: -653K
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +17.1%
Financial Fact:
Income (loss) from operations: -653K
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q1 EPS of $0.06. Revenue for the quarter came in at $62.5 thousand, versus $0 reported last year.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Sharon AI surges premarket; New Oriental gains, Medline slips
- The Lovesac Company (LOVE) Tops Q1 EPS by 29c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
